Phototherapy Market Research Report—Forecast till 2027
出 版 商：Market Research Future
出版日期：2021/02/01
頁 數：168頁
文件格式：PDF
價 格：
USD 4,450 (Single-User License)
USD 6,250 (Global-User License)
USD 6,250 (Global-User License)
Phototherapy Market Research Report—Forecast till 2027
Market Snapshot
According to Market Research Future analysis, the Global Phototherapy Market is anticipated to exhibit a 4.61% CAGR during the review period. As per the GBP analysis, skin disease is likely to be the leading cause of non-fatal disease burden worldwide. Skin diseases are more common in men than in women and increases with the age. The monetary weight of psoriasis is around USD 35 billion in the US each year, and treatment costs are ascending than general swelling. Light-radiating diode (LED) phototherapy addresses a practical, protected, solid, and compact psoriasis therapy. Also, it has benefits, including low force utilization, low warmth creation, and a longer life expectancy of the light-radiating unit when contrasted with other light sources.
Global Phototherapy Market is expected to witness a notable market expansion during the study period owing to the rising occurrence of severe skin diseases and the increasing number of preterm and low-weight births. Additionally, the increasing adoption of LED-based phototherapy equipment is also fuelling the growth of the market during the review period. However, the major restraining factor for the growth of the global market is differential awareness and availability between countries and issues in venture capital, start-ups, and collaborations during the forecast period.
Market Segmentation
The global phototherapy market has been classified into product, radiation, application, end-user, and region.
Based on product type, the global market has been segmented into conventional phototherapy equipment, LED phototherapy equipment, fiberoptic phototherapy equipment, germicidal lamps, and accessories. Based on the radiation segment, the global market has been divided into UVA, UVB, and UVC. Based on application type, the global phototherapy market has been segregated into skin disease treatment, neonatal jaundice management, and sterilization. In terms of the end-user segment, the global phototherapy market has been classified into hospital & clinic, dermatology center, and homecare.
Regional Analysis
Geographically, the phototherapy market has been classified into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
Americas is likely to drive the largest phototherapy market is expected to register a 4.63% CAGR during the forecast period owing to the highest market share of 42.60% in 2019. The regional market growth is attributed to the surging demand for skin treatments in the US and Canada. Furthermore, the growing adoption of home phototherapy is fuelling the regional market growth during the review period. Home phototherapy is more patient-friendly in terms of avoiding frequent hospital visits and it is the most cost-effective treatment option for patients with moderate-to-severe psoriasis. Therefore, the phototherapy market in the Americas is likely to exhibit a 4.63% CAGR during the assessment period.
Europe is expected to contribute the second-largest market for the global phototherapy market followed by Asia-Pacific during the review period.
Major Players
The Prominent Players in the report on the Global Phototherapy Market include Signify Holding (Netherlands), Atom Medical Corporation (Japan), National Biological Corporation (US), Solarc Systems Inc. (Canada), GE Healthcare (US), Natus Medical Incorporated (US), Herbert Waldmann GmbH & Co. KG (Germany), Phoenix Medical Systems (P) Ltd (India), The Daavlin Company (US), and Strata Skin Sciences, Inc. (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Market Snapshot
According to Market Research Future analysis, the Global Phototherapy Market is anticipated to exhibit a 4.61% CAGR during the review period. As per the GBP analysis, skin disease is likely to be the leading cause of non-fatal disease burden worldwide. Skin diseases are more common in men than in women and increases with the age. The monetary weight of psoriasis is around USD 35 billion in the US each year, and treatment costs are ascending than general swelling. Light-radiating diode (LED) phototherapy addresses a practical, protected, solid, and compact psoriasis therapy. Also, it has benefits, including low force utilization, low warmth creation, and a longer life expectancy of the light-radiating unit when contrasted with other light sources.
Global Phototherapy Market is expected to witness a notable market expansion during the study period owing to the rising occurrence of severe skin diseases and the increasing number of preterm and low-weight births. Additionally, the increasing adoption of LED-based phototherapy equipment is also fuelling the growth of the market during the review period. However, the major restraining factor for the growth of the global market is differential awareness and availability between countries and issues in venture capital, start-ups, and collaborations during the forecast period.
Market Segmentation
The global phototherapy market has been classified into product, radiation, application, end-user, and region.
Based on product type, the global market has been segmented into conventional phototherapy equipment, LED phototherapy equipment, fiberoptic phototherapy equipment, germicidal lamps, and accessories. Based on the radiation segment, the global market has been divided into UVA, UVB, and UVC. Based on application type, the global phototherapy market has been segregated into skin disease treatment, neonatal jaundice management, and sterilization. In terms of the end-user segment, the global phototherapy market has been classified into hospital & clinic, dermatology center, and homecare.
Regional Analysis
Geographically, the phototherapy market has been classified into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
Americas is likely to drive the largest phototherapy market is expected to register a 4.63% CAGR during the forecast period owing to the highest market share of 42.60% in 2019. The regional market growth is attributed to the surging demand for skin treatments in the US and Canada. Furthermore, the growing adoption of home phototherapy is fuelling the regional market growth during the review period. Home phototherapy is more patient-friendly in terms of avoiding frequent hospital visits and it is the most cost-effective treatment option for patients with moderate-to-severe psoriasis. Therefore, the phototherapy market in the Americas is likely to exhibit a 4.63% CAGR during the assessment period.
Europe is expected to contribute the second-largest market for the global phototherapy market followed by Asia-Pacific during the review period.
Major Players
The Prominent Players in the report on the Global Phototherapy Market include Signify Holding (Netherlands), Atom Medical Corporation (Japan), National Biological Corporation (US), Solarc Systems Inc. (Canada), GE Healthcare (US), Natus Medical Incorporated (US), Herbert Waldmann GmbH & Co. KG (Germany), Phoenix Medical Systems (P) Ltd (India), The Daavlin Company (US), and Strata Skin Sciences, Inc. (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
TABLE OF CONTENT
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
1.2 MARKET ATTRACTIVENESS ANALYSIS
1.2.1 GLOBAL PHOTOTHERAPY MARKET, BY PRODUCT
1.2.1.1 GLOBAL PHOTOTHERAPY MARKET, BY CONVENTIONAL PHOTOTHERAPY EQUIPMENT
1.2.3 GLOBAL PHOTOTHERAPY MARKET, BY RADIATION
1.2.4 GLOBAL PHOTOTHERAPY MARKET, BY APPLICATION
1.2.4.1 GLOBAL PHOTOTHERAPY MARKET, BY SKIN DISEASE TREATMENT
1.2.4.2 GLOBAL PHOTOTHERAPY MARKET, BY STERILIZATION
1.2.5 GLOBAL PHOTOTHERAPY MARKET, BY END USER
1.2.6 GLOBAL PHOTOTHERAPY MARKET, BY REGION
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
3.4 MARKET SIZE ESTIMATION
3.5 FORECAST MODEL
3.6 LIST OF ASSUMPTIONS & LIMITATIONS
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF SEVERE SKIN DISEASES
4.2.2 RISING NUMBER OF PRETERM AND LOW-WEIGHT BIRTHS
4.2.3 RISING ADOPTION OF LED-BASED PHOTOTHERAPY EQUIPMENT
4.2.4 DRIVERS IMPACT ANALYSIS
4.3 RESTRAINTS
4.3.1 DIFFERENTIAL AWARENESS AND AVAILABILITY BETWEEN COUNTRIES
4.3.2 ISSUES IN VENTURE CAPITAL, STARTUPS, AND COLLABORATIONS
4.3.3 RESTRAINTS IMPACT ANALYSIS
4.4 OPPORTUNITIES
4.4.1 RISING ADOPTION OF HOME PHOTOTHERAPY FOR THE TREATMENT OF SKIN DISEASES
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN
5.1.1 R&D AND DESIGNING
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 BARGAINING POWER OF BUYERS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL PHOTOTHERAPY MARKET
5.3.1 OVERVIEW
5.3.2 DEMAND-SUPPLY ANALYSIS
5.3.3 IMPACT ON PRODUCTION
6 GLOBAL PHOTOTHERAPY MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 CONVENTIONAL PHOTOTHERAPY EQUIPMENT
6.2.1 CONVENTIONAL PHOTOTHERAPY EQUIPMENT WITH FLUORESCENT LAMP
6.2.2 CONVENTIONAL PHOTOTHERAPY EQUIPMENT WITH COMPACT FLUORESCENT LAMPS
6.2.2.1 FULL-BODY PHOTOTHERAPY EQUIPMENT
6.2.2.2 PARTIAL-BODY PHOTOTHERAPY EQUIPMENT
6.3 LED PHOTOTHERAPY EQUIPMENT
6.4 FIBEROPTIC PHOTOTHERAPY EQUIPMENT
6.5 GERMICIDAL LAMPS
6.6 ACCESSORIES
7 GLOBAL PHOTOTHERAPY MARKET BY RADIATION
7.1 OVERVIEW
7.2 UVA
7.3 UVB
7.4 UVC
8 GLOBAL PHOTOTHERAPY MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 SKIN DISEASE TREATMENT
8.2.1 PSORIASIS
8.2.2 VITILIGO
8.2.3 ECZEMA
8.2.4 OTHERS
8.3 NEONATAL JAUNDICE MANAGEMENT
8.4 STERILIZATION
8.4.1 HOSPITAL SERVICES
8.4.2 EQUIPMENT
9 GLOBAL PHOTOTHERAPY MARKET BY END USER
9.1 OVERVIEW
9.2 HOSPITAL & CLINIC
9.3 DERMATOLOGY CENTER
9.4 HOMECARE
9.5 LIST OF HOSPITALS AND CLINICS IN THE US
10 GLOBAL PHOTOTHERAPY MARKET, BY REGION
10.1 INTRODUCTION
10.2 AMERICAS
10.2.1 NORTH AMERICA
10.2.1.1 US
10.2.1.2 CANADA
10.2.2 LATIN AMERICA
10.3 EUROPE
10.3.1 WESTERN EUROPE
10.3.1.1 GERMANY
10.3.1.2 FRANCE
10.3.1.3 UK
10.3.1.4 ITALY
10.3.1.5 SPAIN
10.3.1.6 REST OF WESTERN EUROPE
10.3.2 EASTERN EUROPE
10.4 ASIA-PACIFIC
10.4.1 CHINA
10.4.2 INDIA
10.4.3 JAPAN
10.4.4 AUSTRALIA
10.4.5 SOUTH KOREA
10.4.6 REST OF ASIA-PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 MIDDLE EAST
10.5.2 ISRAEL
10.5.3 AFRICA
11 COMPETITIVE LANDSCAPE
11.1 COMPETITIVE OVERVIEW
11.2 COMPETITOR DASHBOARD
11.3 MARKET SHARE ANALYSIS
11.4 MAJOR GROWTH STRATEGIES IN THE GLOBAL PHOTOTHERAPY MARKET
11.5 COMPETITIVE BENCHMARKING
11.6 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL PHOTOTHERAPY MARKET
11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.7.1 CONTRACTS & AGREEMENTS
11.7.2 NEW PRODUCT DEVELOPMENTS/LAUNCHES
11.7.3 COLLABORATIONS/ EXPANSIONS/PARTNERSHIPS/JOINT VENTURES
11.8 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO
11.8.1 SALES & OPERATING INCOME
11.8.2 R&D EXPENDITURE
11.8.3 CURRENT CAPITAL MARKET RATIO
12 COMPANY PROFILES
12.1 SIGNIFY HOLDING
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS/SERVICES OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 GE HEALTHCARE
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 PRODUCTS/SERVICES OFFERED
12.2.4 KEY DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.2.6 KEY STRATEGIES
12.3 NATUS MEDICAL INCORPORATED
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS/SERVICES OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 SWOT ANALYSIS
12.3.6 KEY STRATEGIES
12.4 HERBERT WALDMANN GMBH & CO. KG
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS/SERVICES OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 KEY STRATEGIES
12.5 PHOENIX MEDICAL SYSTEMS (P) LTD
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS/SERVICES OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 KEY STRATEGIES
12.6 ATOM MEDICAL CORPORATION
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS/SERVICES OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 SWOT ANALYSIS
12.6.6 KEY STRATEGIES
12.7 NATIONAL BIOLOGICAL CORPORATION
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS/SERVICES OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 SWOT ANALYSIS
12.7.6 KEY STRATEGIES
12.8 SOLARC SYSTEMS INC.
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS/SERVICES OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 KEY STRATEGIES
12.9 THE DAAVLIN COMPANY
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS/SERVICES OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 SWOT ANALYSIS
12.9.6 KEY STRATEGIES
12.10 STRATA SKIN SCIENCES, INC.
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL OVERVIEW
12.10.3 PRODUCTS/SERVICES OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 SWOT ANALYSIS
12.10.6 KEY STRATEGIES
13 APPENDIX
13.1 REFERENCES
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
1.2 MARKET ATTRACTIVENESS ANALYSIS
1.2.1 GLOBAL PHOTOTHERAPY MARKET, BY PRODUCT
1.2.1.1 GLOBAL PHOTOTHERAPY MARKET, BY CONVENTIONAL PHOTOTHERAPY EQUIPMENT
1.2.3 GLOBAL PHOTOTHERAPY MARKET, BY RADIATION
1.2.4 GLOBAL PHOTOTHERAPY MARKET, BY APPLICATION
1.2.4.1 GLOBAL PHOTOTHERAPY MARKET, BY SKIN DISEASE TREATMENT
1.2.4.2 GLOBAL PHOTOTHERAPY MARKET, BY STERILIZATION
1.2.5 GLOBAL PHOTOTHERAPY MARKET, BY END USER
1.2.6 GLOBAL PHOTOTHERAPY MARKET, BY REGION
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
3.4 MARKET SIZE ESTIMATION
3.5 FORECAST MODEL
3.6 LIST OF ASSUMPTIONS & LIMITATIONS
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF SEVERE SKIN DISEASES
4.2.2 RISING NUMBER OF PRETERM AND LOW-WEIGHT BIRTHS
4.2.3 RISING ADOPTION OF LED-BASED PHOTOTHERAPY EQUIPMENT
4.2.4 DRIVERS IMPACT ANALYSIS
4.3 RESTRAINTS
4.3.1 DIFFERENTIAL AWARENESS AND AVAILABILITY BETWEEN COUNTRIES
4.3.2 ISSUES IN VENTURE CAPITAL, STARTUPS, AND COLLABORATIONS
4.3.3 RESTRAINTS IMPACT ANALYSIS
4.4 OPPORTUNITIES
4.4.1 RISING ADOPTION OF HOME PHOTOTHERAPY FOR THE TREATMENT OF SKIN DISEASES
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN
5.1.1 R&D AND DESIGNING
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 BARGAINING POWER OF BUYERS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL PHOTOTHERAPY MARKET
5.3.1 OVERVIEW
5.3.2 DEMAND-SUPPLY ANALYSIS
5.3.3 IMPACT ON PRODUCTION
6 GLOBAL PHOTOTHERAPY MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 CONVENTIONAL PHOTOTHERAPY EQUIPMENT
6.2.1 CONVENTIONAL PHOTOTHERAPY EQUIPMENT WITH FLUORESCENT LAMP
6.2.2 CONVENTIONAL PHOTOTHERAPY EQUIPMENT WITH COMPACT FLUORESCENT LAMPS
6.2.2.1 FULL-BODY PHOTOTHERAPY EQUIPMENT
6.2.2.2 PARTIAL-BODY PHOTOTHERAPY EQUIPMENT
6.3 LED PHOTOTHERAPY EQUIPMENT
6.4 FIBEROPTIC PHOTOTHERAPY EQUIPMENT
6.5 GERMICIDAL LAMPS
6.6 ACCESSORIES
7 GLOBAL PHOTOTHERAPY MARKET BY RADIATION
7.1 OVERVIEW
7.2 UVA
7.3 UVB
7.4 UVC
8 GLOBAL PHOTOTHERAPY MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 SKIN DISEASE TREATMENT
8.2.1 PSORIASIS
8.2.2 VITILIGO
8.2.3 ECZEMA
8.2.4 OTHERS
8.3 NEONATAL JAUNDICE MANAGEMENT
8.4 STERILIZATION
8.4.1 HOSPITAL SERVICES
8.4.2 EQUIPMENT
9 GLOBAL PHOTOTHERAPY MARKET BY END USER
9.1 OVERVIEW
9.2 HOSPITAL & CLINIC
9.3 DERMATOLOGY CENTER
9.4 HOMECARE
9.5 LIST OF HOSPITALS AND CLINICS IN THE US
10 GLOBAL PHOTOTHERAPY MARKET, BY REGION
10.1 INTRODUCTION
10.2 AMERICAS
10.2.1 NORTH AMERICA
10.2.1.1 US
10.2.1.2 CANADA
10.2.2 LATIN AMERICA
10.3 EUROPE
10.3.1 WESTERN EUROPE
10.3.1.1 GERMANY
10.3.1.2 FRANCE
10.3.1.3 UK
10.3.1.4 ITALY
10.3.1.5 SPAIN
10.3.1.6 REST OF WESTERN EUROPE
10.3.2 EASTERN EUROPE
10.4 ASIA-PACIFIC
10.4.1 CHINA
10.4.2 INDIA
10.4.3 JAPAN
10.4.4 AUSTRALIA
10.4.5 SOUTH KOREA
10.4.6 REST OF ASIA-PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 MIDDLE EAST
10.5.2 ISRAEL
10.5.3 AFRICA
11 COMPETITIVE LANDSCAPE
11.1 COMPETITIVE OVERVIEW
11.2 COMPETITOR DASHBOARD
11.3 MARKET SHARE ANALYSIS
11.4 MAJOR GROWTH STRATEGIES IN THE GLOBAL PHOTOTHERAPY MARKET
11.5 COMPETITIVE BENCHMARKING
11.6 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL PHOTOTHERAPY MARKET
11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.7.1 CONTRACTS & AGREEMENTS
11.7.2 NEW PRODUCT DEVELOPMENTS/LAUNCHES
11.7.3 COLLABORATIONS/ EXPANSIONS/PARTNERSHIPS/JOINT VENTURES
11.8 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO
11.8.1 SALES & OPERATING INCOME
11.8.2 R&D EXPENDITURE
11.8.3 CURRENT CAPITAL MARKET RATIO
12 COMPANY PROFILES
12.1 SIGNIFY HOLDING
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS/SERVICES OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 GE HEALTHCARE
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 PRODUCTS/SERVICES OFFERED
12.2.4 KEY DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.2.6 KEY STRATEGIES
12.3 NATUS MEDICAL INCORPORATED
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS/SERVICES OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 SWOT ANALYSIS
12.3.6 KEY STRATEGIES
12.4 HERBERT WALDMANN GMBH & CO. KG
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS/SERVICES OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 KEY STRATEGIES
12.5 PHOENIX MEDICAL SYSTEMS (P) LTD
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS/SERVICES OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 KEY STRATEGIES
12.6 ATOM MEDICAL CORPORATION
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS/SERVICES OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 SWOT ANALYSIS
12.6.6 KEY STRATEGIES
12.7 NATIONAL BIOLOGICAL CORPORATION
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS/SERVICES OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 SWOT ANALYSIS
12.7.6 KEY STRATEGIES
12.8 SOLARC SYSTEMS INC.
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS/SERVICES OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 KEY STRATEGIES
12.9 THE DAAVLIN COMPANY
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS/SERVICES OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 SWOT ANALYSIS
12.9.6 KEY STRATEGIES
12.10 STRATA SKIN SCIENCES, INC.
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL OVERVIEW
12.10.3 PRODUCTS/SERVICES OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 SWOT ANALYSIS
12.10.6 KEY STRATEGIES
13 APPENDIX
13.1 REFERENCES
